YOUNG JOON KI

Dr. YOUNG JOON KI

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
DKDong Joon KIM
Dong Joon KIM
YKYOUNG JOON KI
YOUNG JOON KI
JHJang Bo Hyun
Jang Bo Hyun
SKSeongcheol Kim
Seongcheol Kim
SKSang Hun Kim
Sang Hun Kim
Ki Tae JungKi Tae Jung
Ki Tae Jung
Background: Recently, there have been some trials to use dexmedetomidine in the obstetric field but concerns regarding the drug include changes in uterine contractions after labor. We aimed to evaluate the effects of dexmedetomidine on the myometrial contractions of pregnant rats.Methods: In a pilot study, the contraction of the myometrial strips of pregnant Sprague-Dawley rats in an organ bath with oxytocin at 1 mU/ml was assessed by adding dexmedetomidine from 10-6 to 10-2 M accumulatively every 20 min, and active tension and the number of contractions were evaluated. Then, changes in myometrial contractions were evaluated from high doses of dexmedetomidine (1.0 × 10−4 to 1.2 × 10−3 M). The effective concentrations (EC) for changes in uterine contractions were calculated using a probit model.Results: Active tension and the number of contractions were significantly decreased at 10-3 M and 10-4 M dexmedetomidine, respectively (P < 0.05). A complete loss of contractions was seen at 10-2 M. Dexmedetomidine (1.0 × 10−4 to 1.2 × 10−3 M) decreased active tension and the number of contractions in a concentration-dependent manner. The EC95 of dexmedetomidine for inhibiting active tension and the number of contractions was 5.16 × 10-2 M and 2.55 × 10-5 M, respectively.Conclusions: Active tension of the myometrium showed a significant decrease at concentrations of dexmedetomidine higher than 10-3 M. Thus, clinical concentrations of dexmedetomidine may inhibit uterine contractions. Further research is needed for the safe use of dexmedetomidine in the obstetrics field.

30 October 2020 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
HLHyun Young Lee
Hyun Young Lee
YKYOUNG JOON KI
YOUNG JOON KI
SPSu Yeong Park
Su Yeong Park
SCSoo Yeon Cho
Soo Yeon Cho
JSJinyoung Seo
Jinyoung Seo
Ki Tae JungKi Tae Jung
Ki Tae Jung
Background: Cimifugin is one of the components of the root of Saposhnikovia divaricata. The extract derived from S. divaricata is traditionally used as an analgesic. This study was conducted to evaluate the analgesic effect of intrathecal cimifugin in the formalin test.Methods: Male Sprague–Dawley rats (n = 20) were randomized into four groups for intrathecal administration of 70% dimethylsulfoxide and various doses of cimifugin (100 μg, 300 μg, and 1,000 μg). The typical flinch response after the injection of 5% formalin into the hind paw was assessed in two distinct phases: phase 1 until 10 min, and phase 2 from 10 min to 60 min. ED50 values were calculated via linear regression.Results: Intrathecal cimifugin significantly reduced the flinch response in both phases of the formalin test. Significant antinociceptive effects of cimifugin were found with the dose of 300 μg in phase 1 and the dose of 100 μg in phase 2. The ED50 value (95% confidence intervals) of intrathecal cimifugin was 696.1 (360.8–1,342.8) μg during phase 1 and 1,242.8 (42.0–48,292.5) μg during phase 2.Conclusions: Intrathecal cimifugin has an antinociceptive effect against formalin-induced pain. Cimifugin has an anti-inflammatory effect at low concentrations, and non-inflammatory analgesic effect at higher concentrations.

1 January 2020 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
SOSeon-Hee Oh
Seon-Hee Oh
HLHyun Young Lee
Hyun Young Lee
YKYOUNG JOON KI
YOUNG JOON KI
SKSang Hun Kim
Sang Hun Kim
KLKyung Joon Lim
Kyung Joon Lim
Ki Tae JungKi Tae Jung
Ki Tae Jung
Seon Hee Oh, Hyun Young Lee, Young Joon Ki, Sang Hun Kim, Kyung Joon Lim, and Ki Tae Jung. Korean J Pain 2020;33:30-9. https://doi.org/10.3344/kjp.2020.33.1.30

21 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
JJJihyeon Jeon
Jihyeon Jeon
HRHyunseung Ryu
Hyunseung Ryu
MLMyeongjin Lee
Myeongjin Lee
EBEun Hui Bae
Eun Hui Bae
SKSoo Wan Kim
Soo Wan Kim
SPSuhyung Park
Suhyung Park
Background/Objectives: Ultrasound-guided biopsy is essential for accurate needle placement in minimally invasive procedures. However, the limited availability of labeled medical data significantly constrains the development of needle segmentation models, and existing semi-supervised approaches rely solely on data-driven consistency constraints without incorporating domain-specific dynamic properties of the imaging process. We propose a semi-supervised unrolling optimization framework that combines dynamics-based data consistency with self-training. Methods: (1) A null-space projection-based Analytic Model (A) layer is unrolled into the network to suppress background interference and enforce dynamics-based constraints derived from temporal ultrasound sequences, in which the background subspace is estimated via singular value decomposition (SVD) of consecutive frames and the needle signal is recovered by projecting the observed image onto the orthogonal complement of this subspace. (2) A self-training strategy leverages unlabeled ultrasound data by generating soft pseudo-labels from a pretrained teacher network to iteratively supervise the student model, which shares the same unrolling architecture and is jointly trained with a supervised loss on labeled data and a pseudo loss on unlabeled data. Results: Evaluation on an ultrasound needle segmentation dataset demonstrated that the proposed method achieved a Dice score of 0.7429±0.0489 and an IoU of 0.5967±0.0917, outperforming the supervised UnrollNet baseline (Dice: 0.7298±0.0518), Co-Training (U-Net) (Dice: 0.6104±0.0949), and Meta Pseudo Labels (Dice: 0.6426±0.1140). The proposed method also yielded a mean trajectory angle error of 0.66∘±0.63∘ and a tip position error of 0.95mm±0.74mm. Conclusions: These results indicate the potential of the proposed framework for ultrasound-guided needle tracking.